William E Klunk Selected Research

Synaptosomal-Associated Protein 25

1/2021	Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
1/2020	Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William E Klunk Research Topics

Disease

109	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2002
38	Cognitive Dysfunction 01/2022 - 03/2006
34	Dementia (Dementias) 01/2022 - 01/2008
23	Down Syndrome (Down's Syndrome) 01/2022 - 11/2012
23	Amyloid Plaque 01/2020 - 02/2002
11	Atrophy 01/2022 - 08/2005
5	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2021 - 03/2007
5	Amyloidosis 01/2021 - 12/2011
5	Psychotic Disorders (Schizoaffective Disorder) 08/2015 - 01/2002
4	Tauopathies 01/2020 - 11/2015
3	Disease Progression 04/2022 - 11/2010
3	Inflammation (Inflammations) 04/2022 - 02/2012
3	Neuroinflammatory Diseases 01/2021 - 01/2009
3	Neurobehavioral Manifestations 01/2020 - 01/2016
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 11/2015
2	Heart Diseases (Heart Disease) 01/2021 - 09/2013
2	Trisomy (Trisomies) 01/2021 - 11/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 12/2016
2	Corticobasal Degeneration 11/2015 - 09/2013
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2015 - 01/2008
2	Frontotemporal Dementia (Semantic Dementia) 05/2015 - 01/2008
1	Cerebral Cortical Thinning 01/2022
1	Vascular Diseases (Vascular Disease) 09/2021
1	Gliosis 01/2021
1	Hippocampal Sclerosis 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2019
1	Prodromal Symptoms 01/2019
1	Death (Near-Death Experience) 12/2016
1	Multiple System Atrophy 11/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2015
1	Pathologic Processes 12/2014
1	Amyloid angiopathy 01/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2014
1	Parkinson Disease (Parkinson's Disease) 10/2013
1	Diabetes Mellitus 09/2013
1	Stroke (Strokes) 09/2013
1	Hypertension (High Blood Pressure) 09/2013
1	Edema (Dropsy) 02/2012
1	Hemorrhagic Stroke 09/2007
1	Hemorrhage 09/2007

Drug/Important Bio-Agent (IBA)

104	Amyloid (Amyloid Fibrils)IBA 04/2022 - 02/2002
34	Biomarkers (Surrogate Marker)IBA 04/2022 - 10/2003
34	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022 - 06/2003
24	Amyloid beta-PeptidesIBA 01/2021 - 11/2002
11	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2002
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2005
7	LigandsIBA 01/2017 - 07/2004
5	ApolipoproteinsIBA 01/2018 - 01/2002
4	Peptides (Polypeptides)IBA 01/2019 - 06/2008
4	CarbonIBA 04/2016 - 10/2007
3	Coloring Agents (Dyes)IBA 01/2021 - 11/2012
3	flutemetamolIBA 10/2020 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2006
2	thioflavin TIBA 01/2021 - 10/2007
2	Chitinase-3-Like Protein 1IBA 01/2021 - 01/2020
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2018
2	Synaptosomal-Associated Protein 25IBA 01/2021 - 01/2020
2	NeurocalcinIBA 01/2021 - 01/2020
2	alpha-SynucleinIBA 01/2020 - 10/2013
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 11/2015
2	tau Proteins (tau Protein)IBA 01/2017 - 08/2012
2	bapineuzumabIBA 08/2015 - 04/2010
2	Monoclonal AntibodiesIBA 02/2012 - 04/2010
2	Pharmaceutical PreparationsIBA 11/2010 - 10/2007
1	antineoplaston A10 (A 10)IBA 01/2022
1	splenotritin (TP3)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2021
1	NeurograninIBA 01/2020
1	CytokinesIBA 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	Becaplermin (PDGF-BB)FDA Link 01/2019
1	DiureticsIBA 01/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	TenascinIBA 01/2016
1	SynucleinsIBA 11/2015
1	EmulsionsIBA 11/2015
1	pentamer formyl thiophene acetic acidIBA 07/2015
1	CholesterolIBA 04/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2014
1	TritiumIBA 01/2014
1	Contrast MediaIBA 10/2013
1	Antipsychotic Agents (Antipsychotics)IBA 09/2013
1	RheniumIBA 03/2013
1	PresenilinsIBA 11/2012
1	gantenerumabIBA 02/2012
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2009
1	PK 11195 (PK11195)IBA 08/2009
1	amyloid beta-protein (1-42)IBA 06/2009
1	Complement System Proteins (Complement)IBA 01/2008
1	hydroxide ionIBA 01/2008
1	Protein AggregatesIBA 01/2006

Therapy/Procedure

11	Therapeutics 01/2020 - 09/2002
1	Immunotherapy 01/2021
1	Secondary Prevention 08/2015
1	Institutionalization (Institutionalized Persons) 09/2013
1	Home Nursing (Nursing, Home) 09/2013